| | | | |

FiberSweet for Prevention and Treatment of Flu and COVID-19

FiberSweet for Prevention and Treatment of Flu and COVID-19: Modulating Immunity via the Gut-Lung Axis

FiberSweet—a synergistic blend of Ayurvedic-inspired digestive resistant soluble fiber and the probiotic Bacillus coagulans MTCC 5856—can be used as an adjunctive strategy to help prevent and mitigate respiratory viral infections including the flu and COVID-19 by modulating the gut-lung axis, an important immune communication pathway linking gut microbes and lung health .

Scientific evidence shows that fermentable fibers in FiberSweet are metabolized by gut bacteria into short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate, which regulate immune responses both locally and systemically. SCFAs balance inflammatory cytokine production (e.g., IL-1β, IL-18), promote alveolar macrophage function, and enhance antiviral CD8+ T cell activity, collectively reducing lung inflammation and supporting viral clearance in experimental influenza models .

Bacillus coagulans MTCC 5856 complements these effects by enhancing gut barrier integrity, promoting SCFA production, modulating systemic inflammatory pathways, and boosting overall immune function. Clinical trials have demonstrated safety and beneficial immunomodulatory effects of Bacillus coagulans MTCC 5856, making it a promising adjunctive agent in respiratory infection management .

Due to the high mutation rates and variability of respiratory viruses like influenza and SARS-CoV-2, definitive vaccines and antiviral drugs remain limited in efficacy for some strains. Thus, probiotics and prebiotics—such as those in FiberSweet—serve as rational adjunctive tools for modulating immune function and reducing antibiotic side effects during viral infections . Researchers and clinicians are particularly encouraged to consider probiotics, including Bacillus coagulans, in managing COVID-19 patients, including those mechanically ventilated, for potential benefits in immune regulation and secondary infection control .

Mechanisms Supporting Viral Defense by FiberSweet include:

  • SCFA-induced regulation of hematopoiesis, generating monocytes that temper lung inflammation .
  • Enhancement of antiviral T cell metabolism and function .
  • Strengthening of gut mucosal barriers and systemic inflammation reduction by Bacillus coagulans MTCC 5856 .

Practical Application:

Regular use of FiberSweet over weeks supports beneficial microbiota shifts, immune homeostasis, and may reduce the severity of respiratory viral infections. While more targeted clinical trials are warranted, current evidence supports FiberSweet as part of an integrative immune support strategy against flu and COVID-19.

Key References and Resources

  1. McNabney SM, Henagan TM. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, acetate and propionate. Nutrients. 2017;9(12):1341.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745504/
  2. Sen S, et al. Probiotic Bacillus coagulans MTCC 5856 improves immune response in healthy adults: a randomized clinical trial. J Food Sci Technol. 2019;56(2):664-671.
    https://pubmed.ncbi.nlm.nih.gov/30120055/
  3. Hasan NJ et al. Bacillus coagulans supplementation reduces systemic inflammation and improves gastrointestinal function: A meta-analysis. Clin Nutr ESPEN. 2023.
  4. ClinicalTrials.gov: Bacillus coagulans MTCC 5856 studies.
    https://clinicaltrials.gov/ct2/results?cond=&term=Bacillus+coagulans+MTCC+5856
  5. Baindara P, et al. The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment. Microbiol Res. 2021 Nov;12:1727.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539817/

This comprehensive synthesis encourages the use of FiberSweet, which combines fiber-induced beneficial SCFA production and Bacillus coagulans MTCC 5856 probiotic immune effects, as a scientifically grounded adjunct to prevent and treat flu and COVID-19. Researchers and clinicians should consider probiotics as part of holistic infection management strategies, especially in vulnerable populations.

Similar Posts